Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

ETR/QS51 stock hub

ETR/QS51 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/QS51is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

14.8B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/QS51

In the news

Latest news · ETR/QS51

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E26.1

P25 12.3P50 15.7P75 20.2

Trailing P/E38.6

P25 16.4P50 20.9P75 30.4

ROE17

P25 -6.7P50 8.5P75 17.2

ROIC24.6

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/QS51 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

219

Groups with data

Currency

CHF

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	DE
Employees	11,570
Employees Change	6%
Employees Change Percent	0.05
Enterprise value	EUR 14.7B
Exchange	Deutsche Börse Xetra
Financial currency	CHF
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	CH1175448666
Last refreshed	2026-05-10
Market cap	EUR 14.8B
Price	EUR 92.5
Price currency	EUR
Rev Per Employee	241,869.29x
Sector	Healthcare
Sic	3843
Symbol	etr/QS51
Website	https://www.straumann.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.59%
EV Earnings	38.43x
EV/EBIT	21.11x
EV/EBITDA	17.63x
EV/FCF	41.66x
EV/Sales	5.16x
FCF yield	2.39%
Forward P/E	26.12x
P/B ratio	6.35x
P/E ratio	38.62x
P/S ratio	5.28x
PE Ratio10 Y	57.69x
PE Ratio3 Y	46.13x
PE Ratio5 Y	57.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	25.1%
EBITDA Margin	28.81%
FCF margin	12.6%
Gross margin	70.1%
Gross Profit	EUR 2B
Gross Profit Growth	-0.74%
Gross Profit Growth Q	-1.56%
Gross Profit Growth3 Y	1.35%
Gross Profit Growth5 Y	1.19%
Net Income	EUR 382.3M
Net Income Growth	-8.34%
Net Income Growth Q	-24.36%
Net Income Growth3 Y	9.56%
Net Income Growth5 Y	-1.05%
Pretax Margin	17.47%
Profit Margin	13.66%
Profit Per Employee	EUR 33,041
ROA	11.08
Roa5y	11.55
ROCE	21.69
ROE	17.01
Roe5y	24.08
ROIC	24.57
Roic5y	28.46

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-15.64%
Div CAGR10	11.5%
Div CAGR3	10.9%
Div CAGR5	-30.54%
EPS Growth	-8.64
EPS Growth Q	-25.29
EPS Growth3 Y	9.5
EPS Growth5 Y	-1.08
FCF Growth	-10.01%
FCF Growth Q	-10.04%
FCF Growth3 Y	-3.72%
FCF Growth5 Y	2.88%
OCF Growth	4.26%
OCF Growth Q	1.37%
OCF Growth10 Y	2.96%
OCF Growth3 Y	-0.4%
OCF Growth5 Y	2.46%
Revenue Growth	4.05x
Revenue Growth Q	2.16x
Revenue Growth3 Y	2.69x
Revenue Growth5 Y	2.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.71
Assets	EUR 4B
Cash	EUR 525.8M
Current Assets	EUR 1.8B
Current Liabilities	EUR 811.6M
Debt	EUR 450M
Debt EBITDA	EUR 0.54
Debt Equity	EUR 0.19
Debt FCF	EUR 1.28
Equity	EUR 2.3B
Interest Coverage	44.94
Liabilities	EUR 1.7B
Long Term Assets	EUR 2.2B
Long Term Liabilities	EUR 899.9M
Net Cash	EUR 75.9M
Net Cash By Market Cap	EUR 0.51
Net Debt EBITDA	EUR -0.09
Net Debt Equity	EUR -0.03
Net Debt FCF	EUR -0.22
Tangible Book Value	EUR 1.4B
Tangible Book Value Per Share	EUR 8.68
WACC	11.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.21
Inventory Turnover	1.71
Net Working Capital	EUR 466.8M
Quick ratio	1.44
Working Capital	EUR 969.5M
Working Capital Turnover	EUR 3.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.06%
Dividend Growth	14.85%
Dividend Growth Years	2%
Dividend per share	EUR 1.09
Dividend Years	5
Dividend Yield	1.17%
Ex Div Date	2026-04-21
Last Dividend	EUR 1.09
Payout Frequency	Annual
Payout Ratio	42.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-15.63%
200-day SMA	100.4
50-day SMA	93.2
50-day SMA vs 200-day SMA	50under200
All Time High	121.7
All Time High Change	-23.96%
All Time High Date	2025-05-16
All Time Low	80.46
All Time Low Change	14.96%
All Time Low Date	2026-03-23
ATR	2.34
Beta	1.38
Ch YTD	-7.73
High	94
High52	121.7
High52 Date	2025-05-16
High52ch	-23.96%
Low	92.5
Low52	80.46
Low52 Date	2026-03-23
Low52ch	14.96%
Ma50ch	-0.75%
Price vs 200-day SMA	-7.89%
RSI	48.45
RSI Monthly	0
RSI Weekly	44.68
Sharpe ratio	-0.44x
Sortino ratio	-0.48
Total Return	1.11%
Tr YTD	-6.71
Tr1m	7.5%
Tr3m	-13.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 702.4M
Operating Income Growth	2.61
Operating Income Growth Q	-2.51
Operating Income Growth3 Y	0.11
Operating Income Growth5 Y	3.42
Operating margin	25.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	107,918,117%
Net Borrowing	64,550,344
Shares Insiders	32.32%
Shares Institutions	26.41%
Shares Qo Q	0.01%
Shares Yo Y	0.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 332.3M
Average Volume	83.45x
Bv Per Share	14.55
CAPEX	EUR -188.6M
Ch1m	6.32
Ch1y	-16.55
Ch3m	-14.67
Ch6m	-10.84
Change	-1.6%
Change From Open	-1.07
Close	94
Days Gap	-0.53
Depreciation Amortization	105,478,612.6
Dollar Volume	19,980
Earnings Date	2026-04-29
EBIT	EUR 702.4M
EBITDA	EUR 806.2M
EPS	EUR 2.39
F Score	5
FCF	EUR 352.7M
FCF EV Yield	2.4x
Financing CF	-113,800,954
Fiscal Year End	December
Founded	1,954
Goodwill	631,355,732.9
Graham Number	28.0181
Graham Upside	-69.71
Income Tax	EUR 104.2M
Investing CF	-294,197,663
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2025-12-31
Lynch Fair Value	EUR 11.98
Lynch Upside	-87.05
Ma150	98.99
Ma150ch	-6.55%
Ma20	93.83
Ma20ch	-1.41%
Net CF	107,338,152
Next Earnings Date	2026-08-19
Open	93.5
P FCF Ratio	41.87
P OCF Ratio	27.28
Payment Date	2026-04-23
Position In Range	0
Ppne	797,014,758.4
Price Date	2026-05-08
Price EBITDA	EUR 18.31
Ptbv Ratio	10.67
Relative Volume	2.59x
Revenue	2,798,427,667x
SBC By Revenue	0.73x
Share Based Comp	20,352,939
Tax By Revenue	3.73x
Tax Rate	21.33%
Tr6m	-9.85%
Volume	216
Z Score	8.88

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/QS51 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.2%

$1.09 annual per share

Payout ratio

+42.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-30.5%

2 consecutive years of growth

Total shareholder yield

+1.1%

Next ex-dividend date: 2026-04-21

Performance

ETR/QS51 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/QS51?

Insider, institutional, and short-interest positioning.

Institutional ownership

+26.4%

Share of float held by funds and institutions

Insider ownership

+32.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

ETR/QS51 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.4

Neutral momentum band

Price vs 200-day MA

-7.9%

50/200-day relationship not available

Beta (5Y)

1.38

More volatile than the market

Sharpe ratio

-0.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/QS51

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/QS51 stock rating?

etr/QS51 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/QS51 analysis?

The full report lives at /stocks/etr/QS51/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/QS51?

The latest report frames etr/QS51 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/QS51 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.